NCT06312436View on ClinicalTrials.gov

The AT-REBOA Target Trial

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

October 1, 2023

Study Completion Date

December 20, 2024

Conditions
HemorrhageShock, TraumaticCardiac Arrest Due to TraumaPolytrauma
Interventions
PROCEDURE

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)

Temporary aortic occlusion can limit haemorrhage, can help to maintain perfusion to the heart and brain, and may be associated with improved survival.

Trial Locations (2)

1090

Center for Medical Data Science, Vienna

8036

University Medical Centre Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT06312436 - The AT-REBOA Target Trial | Biotech Hunter | Biotech Hunter